Quantcast
Channel: Matthew Lin, MD – 2 Minute Medicine
Viewing all articles
Browse latest Browse all 86

Combination salmeterol-fluticasone therapy noninferior to fluticasone monotherapy for asthma events: The VESTRI trial

$
0
0
1. The rate of adverse asthma-related events was similar in patients with asthma treated with fixed-dosed salmeterol-fluticasone therapy compared to fluticasone monotherapy. 2. The mean percentage of rescue therapy-free days was similar in patients with asthma that were treated with fixed-dosed salmeterol-fluticasone therapy compared to fluticasone monotherapy. Evidence Rating Level: 1 (Excellent) ­ Study Rundown:

Viewing all articles
Browse latest Browse all 86

Trending Articles